Earnings Feed
Start Free
Elanco Animal Health Inc·4

Mar 3, 7:18 PM ET

Simmons Jeffrey N 4

4 · Elanco Animal Health Inc · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-03-01
Elanco Animal Health IncELAN
Simmons Jeffrey N
DirectorPRESIDENT, CEO AND DIRECTOR
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-01+397,041→ 2,200,459 total
  • Tax Payment

    Common Stock

    2026-03-01$26.40/sh−229,982$6,071,525→ 1,970,477 total
  • Award

    Common Stock

    [F2]
    2026-03-01+119,319→ 2,089,796 total
  • Award

    Employee Stock Option (right to buy)

    [F3]
    2026-03-01+243,809→ 243,809 total
    Exercise: $26.40Exp: 2036-03-01→ Common Stock (243,809 underlying)
  • Award

    Deferred Stock Units (Match)

    [F4][F5]
    2026-03-01+6,593→ 6,593 total
    → Common Stock (6,593 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    167,000
Footnotes (5)
  • [F1]Includes 1,038 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.
  • [F2]Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
  • [F3]Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
  • [F4]Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  • [F5]Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons|2026-03-03

Documents

1 file
  • 4
    form4-03042026_120334.xmlPrimary